{"id":2044,"date":"2026-08-27T21:49:15","date_gmt":"2026-08-27T21:49:15","guid":{"rendered":"https:\/\/glacierems.com\/?page_id=2044"},"modified":"2026-08-28T04:55:53","modified_gmt":"2026-08-28T04:55:53","slug":"finasteride-safety-and-monitoring","status":"publish","type":"page","link":"https:\/\/glacierems.com\/index.php\/finasteride-safety-and-monitoring\/","title":{"rendered":"Finasteride Safety and Monitoring: Questions to Review"},"content":{"rendered":"<style>\n.gfw2{--ink:#113f4c;--teal:#1f6c7b;--ice:#eef6f7;--soft:#f3f8f9;--paper:#faf6f1;--copper:#d28243;--border:#c4d7db;max-width:1120px;margin:0 auto;padding:24px;color:#253d45;font:17px\/1.68 Arial,Helvetica,sans-serif;overflow-wrap:anywhere}.gfw2 *{box-sizing:border-box}.gfw2 h1,.gfw2 h2,.gfw2 h3{font-family:Georgia,serif;color:var(--ink);line-height:1.2}.gfw2 h1{font-size:clamp(36px,5vw,58px);margin:.2em 0}.gfw2 h2{font-size:clamp(28px,3vw,38px);margin:1.6em 0 .55em}.gfw2 h3{font-size:23px;margin:.2em 0 .45em}.gfw2 a{color:#165d6b;text-decoration-thickness:1px;text-underline-offset:3px}.gfw2-hero{padding:clamp(28px,6vw,68px);background:var(--paper);border:1px solid var(--border);border-top:8px solid var(--teal)}.gfw2-eyebrow,.gfw2-review-label{color:#8a4f21;font-size:13px;font-weight:800;letter-spacing:.13em;text-transform:uppercase}.gfw2-lead{font-size:21px;max-width:880px}.gfw2-image-pending{margin:28px 0 0;padding:16px 18px;border:2px dashed var(--border);background:white;color:#536c74;font-size:14px}.gfw2-facts,.gfw2-cards{display:grid;grid-template-columns:repeat(4,minmax(0,1fr));gap:14px;margin:22px 0}.gfw2-facts span,.gfw2-card{padding:18px;background:var(--soft);border:1px solid var(--border)}.gfw2-facts span{font-weight:700;color:var(--ink)}.gfw2-review{display:grid;grid-template-columns:96px 1fr;gap:22px;align-items:center;margin:28px 0;padding:24px;background:var(--ice);border:1px solid var(--border);border-top:6px solid var(--teal)}.gfw2-review img{width:96px;height:96px;border-radius:50%;object-fit:cover}.gfw2-review p{margin:4px 0}.gfw2-section{max-width:920px;margin-inline:auto}.gfw2-table-wrap{overflow-x:auto;margin:24px 0}.gfw2 table{width:100%;border-collapse:collapse;min-width:680px}.gfw2 th,.gfw2 td{padding:15px;text-align:left;vertical-align:top;border:1px solid var(--border)}.gfw2 th{background:var(--ink);color:white}.gfw2-callout{margin:30px 0;padding:25px 28px;background:#fff8ec;border-left:7px solid var(--copper)}.gfw2-nav{margin:34px 0;padding:26px;background:var(--ice);border:1px solid var(--border)}.gfw2-nav ul{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:12px 28px}.gfw2 details{margin:12px 0;padding:16px 18px;background:var(--soft);border:1px solid var(--border)}.gfw2 summary{cursor:pointer;font-weight:700;color:var(--ink)}.gfw2-sources{margin-top:42px;padding:26px;background:var(--paper);border-top:6px solid var(--teal)}.gfw2-disclaimer{font-size:14px;color:#5b7077;border-top:1px solid var(--border);padding-top:18px}.gfw2-cta{padding:24px;background:var(--ink);color:white}.gfw2-cta h2,.gfw2-cta a{color:white}@media(max-width:760px){.gfw2{padding:14px}.gfw2-facts,.gfw2-cards{grid-template-columns:1fr 1fr}.gfw2-nav ul{grid-template-columns:1fr}}@media(max-width:640px){.gfw2-review{grid-template-columns:1fr}.gfw2-facts,.gfw2-cards{grid-template-columns:1fr}.gfw2-review img{width:96px;height:96px}.gfw2-hero{padding:24px 18px}}\n<\/style>\n<article class=\"gfw2\" data-page-id=\"fin-hub-safety\" data-role=\"HUB\" data-glacier-wave2-shell=\"layout-v2\">\n<style data-glacier-wave2-hero-style=\"background-v1\">[data-glacier-wave2-shell=\"layout-v2\"]{max-width:1180px;margin-inline:auto;}[data-glacier-wave2-shell=\"layout-v2\"]>section{margin-block:clamp(42px,6vw,72px);}[data-glacier-wave2-hero]{position:relative;isolation:isolate;overflow:hidden;margin-bottom:clamp(38px,5vw,68px)!important;padding:clamp(32px,5vw,64px)!important;border-radius:18px;box-shadow:0 18px 44px rgba(17,63,76,.13);}[data-glacier-wave2-hero]::after{content:\"\";position:absolute;z-index:1;inset:0;background:linear-gradient(90deg,rgba(244,249,250,.94) 0%,rgba(244,249,250,.82) 48%,rgba(17,63,76,.20) 100%);pointer-events:none;}[data-glacier-wave2-hero]>:not([data-glacier-wave2-backdrop]){position:relative;z-index:2;}[data-glacier-wave2-backdrop]{position:absolute;z-index:0;inset:0;width:100%;height:100%;object-fit:cover;filter:none;opacity:1;pointer-events:none;}[data-glacier-product-media]{display:block;width:min(100%,960px);height:auto;aspect-ratio:16\/9;object-fit:cover;margin:clamp(36px,5vw,64px) auto;border:1px solid #c4d7db;border-radius:18px;overflow:hidden;background:#fff;box-shadow:0 18px 42px rgba(17,63,76,.14);}[data-glacier-product-media]>img{display:block;width:100%;height:100%;object-fit:cover;}[data-glacier-wave2-hero] [data-glacier-product-media]{width:min(100%,760px);margin:clamp(30px,4vw,48px) auto 0;}@media(max-width:640px){[data-glacier-wave2-hero]{margin-bottom:38px!important;padding:26px 20px!important;border-radius:14px;}[data-glacier-wave2-hero]::after{background:linear-gradient(180deg,rgba(244,249,250,.94) 0%,rgba(244,249,250,.82) 68%,rgba(17,63,76,.18) 100%);}[data-glacier-wave2-shell=\"layout-v2\"]>section{margin-block:38px;}[data-glacier-product-media]{margin:34px auto;border-radius:14px;}}<\/style>\n<header class=\"gfw2-hero\" data-glacier-wave2-hero=\"background-v1\"><img fetchpriority=\"high\" data-glacier-wave2-backdrop=\"glacier-finasteride-safety-monitoring.webp\" src=\"https:\/\/glacierems.com\/wp-content\/uploads\/2026\/08\/glacier-finasteride-safety-monitoring.webp\" alt=\"Finasteride medication safety checklist and dated symptom log\" width=\"1600\" height=\"900\" loading=\"eager\" decoding=\"async\"><\/p>\n<div class=\"gfw2-eyebrow\">Safety guide \u00b7 Informed decisions<\/div>\n<h2>Finasteride Safety and Monitoring: Questions to Review<\/h2>\n<p class=\"gfw2-lead\">Finasteride safety and monitoring begin before the first tablet. A useful review documents baseline symptoms, other medicines, reproductive and handling precautions, expectations, and the route for reporting changes. It does not assume that every symptom is caused by finasteride, and it does not dismiss new concerns because they are uncomfortable to discuss.<\/p>\n<figure data-glacier-product-media=\"product-glacier-finasteride-safety-monitoring.webp\" style=\"margin:clamp(36px,5vw,64px) 0;position:relative;z-index:2;overflow:hidden;border:1px solid #c4d7db;border-radius:18px;background:#fff;box-shadow:0 18px 42px rgba(17,63,76,.14);\"><img fetchpriority=\"high\" src=\"https:\/\/glacierems.com\/wp-content\/uploads\/2026\/08\/product-glacier-finasteride-safety-monitoring.webp\" alt=\"Propecia and finasteride pharmacy packaging for Finasteride Safety and Monitoring: Questions to Review\" width=\"1600\" height=\"900\" loading=\"eager\" fetchpriority=\"high\" decoding=\"async\" style=\"display:block;width:100%;height:auto;aspect-ratio:16\/9;object-fit:cover;\"><\/figure>\n<div class=\"gfw2-facts\"><span>Baseline before treatment<\/span><span>Report changes directly<\/span><span>Handling matters<\/span><span>Follow-up has a purpose<\/span><\/div>\n<\/header>\n<style data-glacier-reviewer-style=\"canonical-v1\">@media(max-width:640px){[data-glacier-reviewer=\"canonical-v1\"]{flex-direction:column;align-items:flex-start!important;}[data-glacier-reviewer=\"canonical-v1\"]>div{min-width:0!important;width:100%;}}<\/style>\n<section data-glacier-reviewer=\"canonical-v1\" aria-label=\"Medical reviewer\" style=\"display:flex;align-items:center;gap:20px;padding:22px 24px;margin:0 0 30px;border:1px solid #c4d7db;border-top:4px solid #1f6c7b;background:#eef6f7;color:#113f4c;\"><img loading=\"lazy\" src=\"https:\/\/glacierems.com\/wp-content\/uploads\/2026\/08\/michael-eisenberg-original.jpg\" alt=\"Michael L. Eisenberg, MD\" width=\"96\" height=\"96\" loading=\"lazy\" decoding=\"async\" style=\"width:96px;height:96px;flex:0 0 96px;object-fit:cover;border-radius:50%;\"><\/p>\n<div style=\"min-width:0;flex:1;\">\n<p style=\"margin:0 0 4px;font-size:12px;font-weight:800;letter-spacing:.08em;text-transform:uppercase;color:#1f6c7b;\">Medically reviewed by<\/p>\n<p style=\"margin:0 0 5px;font-family:Georgia,serif;font-size:24px;line-height:1.25;font-weight:700;\"><a href=\"https:\/\/glacierems.com\/index.php\/expert-contributors\/michael-eisenberg\/\">Michael L. Eisenberg, MD<\/a><\/p>\n<p style=\"margin:0 0 5px;line-height:1.55;\">Urology and men\u2019s health \u00b7 medication safety and reproductive considerations<\/p>\n<p style=\"margin:0 0 5px;line-height:1.55;\"><strong>Medical review completed August 27, 2026<\/strong><\/p>\n<p style=\"margin:0;\"><a href=\"https:\/\/glacierems.com\/index.php\/expert-contributors\/michael-eisenberg\/\">View Glacier contributor profile<\/a><\/p>\n<\/div>\n<\/section>\n<section class=\"gfw2-section\">\n<h2>A practical decision pathway<\/h2>\n<div class=\"gfw2-cards\">\n<div class=\"gfw2-card\">\n<h3>Before treatment<\/h3>\n<p>Review symptoms, medicines, allergies, health history, pregnancy handling risks in the household, and prostate-related testing.<\/p>\n<\/div>\n<div class=\"gfw2-card\">\n<h3>During treatment<\/h3>\n<p>Keep a dated record of adherence, sexual or mood changes, breast symptoms, allergic symptoms, and other new health events.<\/p>\n<\/div>\n<div class=\"gfw2-card\">\n<h3>At follow-up<\/h3>\n<p>Separate persistent trends from isolated events and decide whether diagnosis, treatment, or monitoring should change.<\/p>\n<\/div>\n<div class=\"gfw2-card\">\n<h3>Urgent situations<\/h3>\n<p>Severe allergic symptoms, difficulty breathing, or immediate danger require emergency care rather than waiting for an online reply.<\/p>\n<\/div>\n<\/div>\n<div class=\"gfw2-table-wrap\">\n<table>\n<thead>\n<tr>\n<th>Observation<\/th>\n<th>Routine response<\/th>\n<th>Escalate when<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>New sexual symptom<\/td>\n<td>Document timing and contact the prescriber<\/td>\n<td>It is persistent, distressing, or changes the treatment decision<\/td>\n<\/tr>\n<tr>\n<td>Mood change<\/td>\n<td>Take it seriously and seek clinical advice<\/td>\n<td>There is suicidal thinking, immediate danger, or severe deterioration<\/td>\n<\/tr>\n<tr>\n<td>Breast change<\/td>\n<td>Arrange prompt medical review<\/td>\n<td>There is a lump, nipple discharge, or marked change<\/td>\n<\/tr>\n<tr>\n<td>Possible exposure in pregnancy<\/td>\n<td>Avoid handling damaged tablets and seek professional advice<\/td>\n<td>A crushed\/broken tablet was handled or exposure is uncertain<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<aside class=\"gfw2-callout\">\n<h2>Do not stop, restart, or change the prescribed schedule from an article<\/h2>\n<p>A clinician who knows the indication and history should guide medication changes. If symptoms are severe or there is immediate danger, seek urgent or emergency help; do not wait for a routine portal response.<\/p>\n<\/aside>\n<section>\n<h2>Why baseline questions improve safety<\/h2>\n<p>A symptom recorded only after treatment begins can be difficult to interpret. Baseline documentation gives the prescriber a clearer comparison. Relevant questions may include sexual function, mood, breast symptoms, fertility concerns, urinary or prostate evaluation, allergies, and other medicines or supplements. The purpose is not to exclude everyone with a concern. It is to make the decision informed and create a plan for change.<\/p>\n<p>The diagnosis should also be revisited. Exposing someone to medication risk is hard to justify when the hair-loss pattern is uncertain. If the history suggests rapid shedding, inflammatory scalp disease, scarring, or another condition, the next step may be examination rather than a finasteride decision.<\/p>\n<\/section>\n<section>\n<h2>Sexual and mood symptoms deserve direct reporting<\/h2>\n<p>The finasteride label includes sexual adverse reactions and postmarketing reports that include sexual dysfunction and depression. A report does not by itself prove cause, and another health condition, medicine, relationship factor, or stressor may contribute. That uncertainty is a reason for clinical review, not a reason to hide or dismiss the symptom.<\/p>\n<p>Record what changed, when it began, whether it is constant or intermittent, and whether anything else changed at the same time. Contact the prescriber when a symptom is troubling, persistent, or affects the treatment decision. Severe depression, suicidal thinking, or immediate danger needs urgent help through emergency or crisis services.<\/p>\n<\/section>\n<section>\n<h2>Pregnancy precautions are about exposure and handling<\/h2>\n<p>Finasteride is not indicated for use in women in the 1 mg hair-loss label. The labeling warns that women who are or may be pregnant should not handle crushed or broken tablets because finasteride can be absorbed through the skin and may affect development of a male fetus. Intact tablets are coated, which prevents contact during normal handling when they are not broken or crushed.<\/p>\n<p>Store medicine in its labeled container, do not split or crush tablets unless a pharmacist specifically addresses the product and safety, and keep medication away from children and anyone for whom it was not prescribed. A damaged tablet or possible pregnancy exposure should be discussed with a pharmacist or clinician rather than managed from general web advice. <span class=\"gw2-inline-context\" data-gw2-inline-context=\"1\">For more detail on this decision, review <a href=\"\/index.php\/finasteride-online-for-hair-loss\/\">Prescription access<\/a>.<\/span><\/p>\n<\/section>\n<section>\n<h2>Monitoring should answer a defined question<\/h2>\n<p>Monitoring is more than watching for a side-effect list. It asks whether the diagnosis still fits, whether the routine is being followed, whether benefits are measurable, and whether new symptoms change the balance. Baseline and follow-up photographs should use consistent conditions. Symptom notes should be dated and specific enough to support a conversation.<\/p>\n<p>Finasteride can affect prostate-specific antigen values, so clinicians interpreting that test need to know about current use. The appropriate test and interpretation depend on age, indication, history, and clinical context. A hair-loss article should not provide a personalized laboratory schedule.<\/p>\n<\/section>\n<section>\n<h2>Topical compounding introduces a separate risk discussion<\/h2>\n<p>FDA\u2019s April 2025 alert states that there is no FDA-approved topical finasteride formulation. The agency described reports of adverse events with compounded topical products and noted local reactions and risk of transfer to other people. A topical route should not be advertised as risk free merely because it is applied to the scalp.<\/p>\n<p>People considering a compounded formulation should ask why it is recommended, what evidence applies, how dosing consistency is managed, what handling steps reduce transfer, and how adverse effects are reported. FDA-approved oral labeling cannot simply be treated as a complete label for a compounded topical product. <span class=\"gw2-inline-context\" data-gw2-inline-context=\"2\">A related clinical question is covered in <a href=\"\/index.php\/services\/online-prescriptions\/categories\/finasteride-side-effects-and-monitoring\/\">Side effects overview<\/a>.<\/span><\/p>\n<\/section>\n<section>\n<h2>Use a simple safety record<\/h2>\n<p>A useful record can fit on one page: treatment start date, product and pharmacy, current medicines, baseline symptoms, new symptoms with dates, interruptions, and questions for the next contact. Avoid copying long lists of every possible symptom into a daily diary. The goal is to notice meaningful change and communicate it clearly, not to create constant surveillance.<\/p>\n<p>Bring the same record to other clinicians. Emergency, primary care, mental-health, urology, dermatology, and pharmacy professionals may each need to know that finasteride is being used. Do not assume that a medicine prescribed online automatically appears in every health system. An updated medication list reduces that gap.<\/p>\n<p>Report suspected adverse events through the treating team and, when appropriate, FDA MedWatch. Reporting is not the same as proving causation; it contributes information that regulators and clinicians can assess. Preserve the product label, lot information when available, dispensing pharmacy, dates, and a factual description. Avoid altering the medicine or packaging before a pharmacist has answered a product-quality question.<\/p>\n<\/section>\n<section>\n<h2>Questions for the reviewing clinician<\/h2>\n<p>Ask which baseline symptoms are most useful to document, how to report a change, what constitutes an urgent concern, and whether other clinicians need to know about finasteride use. Clarify pregnancy handling precautions for the actual product and household. Ask how prostate-related test results should be communicated.<\/p>\n<p>Also ask what evidence would change the treatment decision. A good answer connects benefit, burden, and safety rather than focusing only on a single symptom or photograph. Write down the contact route and review interval. If instructions conflict between a product label, pharmacy message, and care plan, contact the prescriber or dispensing pharmacist instead of choosing the most convenient version. Keep the final instructions with the medication record.<\/p>\n<\/section>\n<nav class=\"gfw2-nav\" aria-label=\"Related finasteride guidance\">\n<h2>Continue through this finasteride guide<\/h2>\n<ul>\n<li><a href=\"\/index.php\/finasteride-online-for-hair-loss\/\">Prescription access<\/a><\/li>\n<li><a href=\"\/index.php\/services\/online-prescriptions\/categories\/finasteride-side-effects-and-monitoring\/\">Side effects overview<\/a><\/li>\n<li><a href=\"\/index.php\/finasteride-pregnancy-handling-precautions\/\">Pregnancy handling precautions<\/a><\/li>\n<li><a href=\"\/index.php\/finasteride-sexual-side-effects\/\">Sexual side effects<\/a><\/li>\n<\/ul>\n<\/nav>\n<section>\n<h2>Frequently asked questions<\/h2>\n<details>\n<summary>What should be recorded before taking finasteride?<\/summary>\n<p>Document relevant baseline symptoms, medicines, health history, treatment goals, and any household pregnancy-handling concerns.<\/p>\n<\/details>\n<details>\n<summary>Should sexual side effects be reported?<\/summary>\n<p>Yes. Troubling or persistent changes should be discussed directly with the prescriber so timing and other possible causes can be assessed.<\/p>\n<\/details>\n<details>\n<summary>Can a pregnant person handle finasteride tablets?<\/summary>\n<p>The label warns against handling crushed or broken tablets. Intact tablets are coated; ask a pharmacist about any damaged-tablet exposure.<\/p>\n<\/details>\n<details>\n<summary>Does finasteride affect PSA?<\/summary>\n<p>Finasteride can affect prostate-specific antigen values. Tell the clinician interpreting the test that you use it.<\/p>\n<\/details>\n<details>\n<summary>Is topical finasteride automatically safer?<\/summary>\n<p>No. FDA has warned about risks with compounded topical finasteride and states that no topical formulation is FDA approved.<\/p>\n<\/details>\n<details>\n<summary>When is emergency care appropriate?<\/summary>\n<p>Severe allergic symptoms, difficulty breathing, suicidal crisis, or immediate danger requires urgent or emergency help.<\/p>\n<\/details>\n<\/section>\n<section class=\"gfw2-sources\">\n<h2>Primary and clinical sources<\/h2>\n<ul>\n<li><a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=abd87058-923f-4767-986c-278201c0e688\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" referrerpolicy=\"no-referrer\">DailyMed \/ U.S. National Library of Medicine: Finasteride 1 mg prescribing information<\/a> \u2014 Label updated November 23, 2022; checked August 27, 2026.<\/li>\n<li><a href=\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/fda-alerts-health-care-providers-compounders-and-consumers-potential-risks-associated-compounded\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" referrerpolicy=\"no-referrer\">U.S. Food and Drug Administration: Potential risks associated with compounded topical finasteride products<\/a> \u2014 Published April 22, 2025; checked August 27, 2026.<\/li>\n<\/ul>\n<\/section>\n<p class=\"gfw2-disclaimer\">Educational information only. This page does not diagnose hair loss, provide individualized dosing, guarantee a prescription, or replace urgent or in-person care when needed.<\/p>\n<\/section>\n<\/article>\n<p><script type=\"application\/ld+json\" data-glacier-wave2-schema>{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"MedicalWebPage\",\"@id\":\"https:\/\/glacierems.com\/index.php\/finasteride-safety-and-monitoring\/#webpage\",\"url\":\"https:\/\/glacierems.com\/index.php\/finasteride-safety-and-monitoring\/\",\"name\":\"Finasteride Safety and Monitoring: Questions to Review\",\"headline\":\"Finasteride Safety and Monitoring: Questions to Review\",\"description\":\"Review finasteride safety topics, side-effect reporting, pregnancy handling precautions, monitoring records, and when to contact a clinician.\",\"dateModified\":\"2026-08-27\",\"lastReviewed\":\"2026-08-27\",\"reviewedBy\":{\"@type\":\"Person\",\"@id\":\"https:\/\/glacierems.com\/index.php\/expert-contributors\/michael-eisenberg\/#person\",\"name\":\"Michael L. Eisenberg, MD\",\"url\":\"https:\/\/glacierems.com\/index.php\/expert-contributors\/michael-eisenberg\/\",\"image\":\"https:\/\/glacierems.com\/wp-content\/uploads\/2026\/08\/michael-eisenberg-original.jpg\"},\"breadcrumb\":{\"@id\":\"https:\/\/glacierems.com\/index.php\/finasteride-safety-and-monitoring\/#breadcrumb\"},\"isPartOf\":{\"@type\":\"WebSite\",\"@id\":\"https:\/\/glacierems.com\/#website\",\"url\":\"https:\/\/glacierems.com\/\"},\"about\":[{\"@type\":\"Drug\",\"name\":\"Finasteride\"},{\"@type\":\"MedicalCondition\",\"name\":\"Male pattern hair loss\"}],\"primaryImageOfPage\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/glacierems.com\/index.php\/finasteride-safety-and-monitoring\/#primaryimage\",\"url\":\"https:\/\/glacierems.com\/wp-content\/uploads\/2026\/08\/product-glacier-finasteride-safety-monitoring.webp\",\"contentUrl\":\"https:\/\/glacierems.com\/wp-content\/uploads\/2026\/08\/product-glacier-finasteride-safety-monitoring.webp\",\"caption\":\"Propecia and finasteride pharmacy packaging for Finasteride Safety and Monitoring: Questions to Review\",\"width\":1600,\"height\":900}},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/glacierems.com\/index.php\/finasteride-safety-and-monitoring\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/glacierems.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Finasteride guides\",\"item\":\"https:\/\/glacierems.com\/index.php\/finasteride-safety-and-monitoring\/\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/glacierems.com\/index.php\/expert-contributors\/michael-eisenberg\/#person\",\"name\":\"Michael L. Eisenberg, MD\",\"url\":\"https:\/\/glacierems.com\/index.php\/expert-contributors\/michael-eisenberg\/\",\"image\":\"https:\/\/glacierems.com\/wp-content\/uploads\/2026\/08\/michael-eisenberg-original.jpg\",\"jobTitle\":\"Urologist and male reproductive health physician\"}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Review finasteride safety topics, side-effect reporting, pregnancy handling precautions, monitoring records, and when to contact a clinician.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-2044","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/glacierems.com\/index.php\/wp-json\/wp\/v2\/pages\/2044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/glacierems.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/glacierems.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/glacierems.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/glacierems.com\/index.php\/wp-json\/wp\/v2\/comments?post=2044"}],"version-history":[{"count":4,"href":"https:\/\/glacierems.com\/index.php\/wp-json\/wp\/v2\/pages\/2044\/revisions"}],"predecessor-version":[{"id":2520,"href":"https:\/\/glacierems.com\/index.php\/wp-json\/wp\/v2\/pages\/2044\/revisions\/2520"}],"wp:attachment":[{"href":"https:\/\/glacierems.com\/index.php\/wp-json\/wp\/v2\/media?parent=2044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}